OT-101, an 18-mer phosphorothioate ASO, was designed for the targeted inhibition of human TGF-β2 mRNA, and OT-101 has suppressed TGF-β2 secretion in human pancreatic cancer cell lines [22,23,24]. This evidence concerns the gene TGFB2 and familial pancreatic carcinoma.